FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101629229> ?p ?o ?g. }

• W2101629229 abstract "Restless Legs Syndrome is a neuropathic disorder seen in end stage renal disease. Since biotin is dialyzable, we examined the relationship between biotin status and Restless Legs Syndrome in end stage renal disease (Study 1) and determined the effect of biotin supplementation on Restless Legs Syndrome symptoms (Study 2). Comparison of prevalence of biotin deficiency in those with and without Restless Legs Syndrome (Study 1) and randomized assignment, double-blinded, placebo-controlled study of biotin supplementation (Study 2) were in a medical center’s outpatient dialysis unit. In Study 1, patients received chronic dialysis and routine biotin supplementation at ≈300 μg daily (10 times the recommended dietary allowance). In the intervention Study 2, biotin was supplemented at 10,000 μg daily for 8 weeks; the placebo group received ≈300 μg of biotin daily. Outcome was measured by Restless Legs Syndrome symptom score and biotin status as indicated by activation coefficient of the biotin-dependent enzyme propionyl-CoA carboxylase in peripheral blood lymphocytes. In Study 1, patients with (n=30) were more likely than those without (n=19) Restless Legs Syndrome to be biotin deficient as judged by increased activation coefficient of propionyl-CoA carboxylase; mean (± 1SD) was 1.17 ± 0.65 vs. 0.87 ± 0.39, respectively (P=0.007). In Study 2, Restless Legs Syndrome score of the biotin group (n=16), improved from 20 ± 6 to 13 ± 11 (P=0.001). However, in the placebo group (n=15), Restless Legs Syndrome score also improved from 17 ± 8 to 12 ± 10 (P=0.01). Consequently, this change was not different between biotin and placebo. Mean activation coefficient of propionyl-CoA carboxylase of the biotin group (n=8) improved from 1.38 ± 0.76 to 0.81 ± 0.25 (P=0.01) and did not change in the placebo group (0.98 ± 0.44 vs. 1.17 ± 0.32; P=0.17). The improvement of biotin status and of Restless Legs Syndrome score with the 10,000 μg supplement suggests that large biotin supplements might be necessary to optimize biotin status in dialysis patients." @default.
• W2101629229 created "2016-06-24" @default.
• W2101629229 creator A5019079377 @default.
• W2101629229 creator A5025616276 @default.
• W2101629229 creator A5032765581 @default.
• W2101629229 creator A5038561830 @default.
• W2101629229 creator A5047614139 @default.
• W2101629229 date "2012-01-01" @default.
• W2101629229 modified "2023-09-30" @default.
• W2101629229 title "Biotin Deficiency as a Target for Treating Restless Legs Syndrome in Chronic Dialysis Patients" @default.
• W2101629229 cites W1827655143 @default.
• W2101629229 cites W1917435033 @default.
• W2101629229 cites W1975104832 @default.
• W2101629229 cites W1980663409 @default.
• W2101629229 cites W1991726737 @default.
• W2101629229 cites W1993586526 @default.
• W2101629229 cites W2026736163 @default.
• W2101629229 cites W2045099422 @default.
• W2101629229 cites W2063164272 @default.
• W2101629229 cites W2065899762 @default.
• W2101629229 cites W2076723998 @default.
• W2101629229 cites W2076795343 @default.
• W2101629229 cites W2091605545 @default.
• W2101629229 cites W2094682665 @default.
• W2101629229 cites W2098836262 @default.
• W2101629229 cites W2107621321 @default.
• W2101629229 cites W2123262581 @default.
• W2101629229 cites W2150770295 @default.
• W2101629229 cites W2161137781 @default.
• W2101629229 cites W2163902185 @default.
• W2101629229 cites W2399545214 @default.
• W2101629229 cites W2408114703 @default.
• W2101629229 cites W2408799309 @default.
• W2101629229 cites W2417699129 @default.
• W2101629229 cites W2575099486 @default.
• W2101629229 doi "https://doi.org/10.4172/2161-0959.1000128" @default.
• W2101629229 hasPublicationYear "2012" @default.
• W2101629229 type Work @default.
• W2101629229 sameAs 2101629229 @default.
• W2101629229 citedByCount "1" @default.
• W2101629229 countsByYear W21016292292015 @default.
• W2101629229 crossrefType "journal-article" @default.
• W2101629229 hasAuthorship W2101629229A5019079377 @default.
• W2101629229 hasAuthorship W2101629229A5025616276 @default.
• W2101629229 hasAuthorship W2101629229A5032765581 @default.
• W2101629229 hasAuthorship W2101629229A5038561830 @default.
• W2101629229 hasAuthorship W2101629229A5047614139 @default.
• W2101629229 hasBestOaLocation W21016292291 @default.
• W2101629229 hasConcept C126322002 @default.
• W2101629229 hasConcept C134018914 @default.
• W2101629229 hasConcept C141071460 @default.
• W2101629229 hasConcept C142724271 @default.
• W2101629229 hasConcept C204787440 @default.
• W2101629229 hasConcept C27081682 @default.
• W2101629229 hasConcept C2776294945 @default.
• W2101629229 hasConcept C2776750294 @default.
• W2101629229 hasConcept C2776940978 @default.
• W2101629229 hasConcept C2778204606 @default.
• W2101629229 hasConcept C2781210498 @default.
• W2101629229 hasConcept C55493867 @default.
• W2101629229 hasConcept C71924100 @default.
• W2101629229 hasConcept C86803240 @default.
• W2101629229 hasConcept C90924648 @default.
• W2101629229 hasConcept C98274493 @default.
• W2101629229 hasConceptScore W2101629229C126322002 @default.
• W2101629229 hasConceptScore W2101629229C134018914 @default.
• W2101629229 hasConceptScore W2101629229C141071460 @default.
• W2101629229 hasConceptScore W2101629229C142724271 @default.
• W2101629229 hasConceptScore W2101629229C204787440 @default.
• W2101629229 hasConceptScore W2101629229C27081682 @default.
• W2101629229 hasConceptScore W2101629229C2776294945 @default.
• W2101629229 hasConceptScore W2101629229C2776750294 @default.
• W2101629229 hasConceptScore W2101629229C2776940978 @default.
• W2101629229 hasConceptScore W2101629229C2778204606 @default.
• W2101629229 hasConceptScore W2101629229C2781210498 @default.
• W2101629229 hasConceptScore W2101629229C55493867 @default.
• W2101629229 hasConceptScore W2101629229C71924100 @default.
• W2101629229 hasConceptScore W2101629229C86803240 @default.
• W2101629229 hasConceptScore W2101629229C90924648 @default.
• W2101629229 hasConceptScore W2101629229C98274493 @default.
• W2101629229 hasIssue "06" @default.
• W2101629229 hasLocation W21016292291 @default.
• W2101629229 hasOpenAccess W2101629229 @default.
• W2101629229 hasPrimaryLocation W21016292291 @default.
• W2101629229 hasRelatedWork W1986405021 @default.
• W2101629229 hasRelatedWork W1991993073 @default.
• W2101629229 hasRelatedWork W2011371144 @default.
• W2101629229 hasRelatedWork W2056285112 @default.
• W2101629229 hasRelatedWork W2080831267 @default.
• W2101629229 hasRelatedWork W2094682665 @default.
• W2101629229 hasRelatedWork W2097105350 @default.
• W2101629229 hasRelatedWork W2119433093 @default.
• W2101629229 hasRelatedWork W2154864999 @default.
• W2101629229 hasRelatedWork W2155182125 @default.
• W2101629229 hasRelatedWork W2157507398 @default.
• W2101629229 hasRelatedWork W2160722546 @default.
• W2101629229 hasRelatedWork W2169003962 @default.
• W2101629229 hasRelatedWork W2354933927 @default.
• W2101629229 hasRelatedWork W2355446190 @default.
• W2101629229 hasRelatedWork W2361830524 @default.

• next